This is a page describing data taken during an experiment at the ISIS Neutron and Muon Source. Information about the ISIS Neutron and Muon Source can be found at https://www.isis.stfc.ac.uk.
A biophysical study of an innovative nanoconstruct designed for theranostic against Multiple Myeloma
Abstract: This project aims to develop a new cancer treatment (theranostic) specific for Multiple myeloma (MM) a hematologic malignancy. This project develops a stimuli-responsive Nanoparticle (NP) coupled to an anticancer drug (Carfilzomib) embedded in a shell of mixed synthetic and natural lipids and which is targeted with monoclonal antibodies. Preliminary data allowed us to study the NP's shape, size and structure. NR will allow us to investigate the interaction between the NP and the membrane of a cell target.
Public release date: 02 August 2027
Principal Investigator: Miss ALICE PICCININI
Experimenter: Dr Guillaume Gilliard
Local Contact: Dr Mario Campana
Experimenter: Dr Valeria Rondelli
DOI: 10.5286/ISIS.E.RB2410531-1
Parent DOI: 10.5286/ISIS.E.RB2410531
ISIS Experiment Number: RB2410531
Part Number: 1
This dataset is NOT yet publicly available.
The release date is: 02 August 2027
Date of Experiment: 25 July 2024
Publisher: STFC ISIS Neutron and Muon Source
Data format: RAW/Nexus
Select the data format above to find
out more about it.
Data Citation
The recommended format for citing this dataset in a research
publication is as:
[author], [date], [title], [publisher],
[doi]
For Example:
Miss ALICE PICCININI et al; (2024): A biophysical study of an innovative nanoconstruct designed for theranostic against Multiple Myeloma, STFC ISIS Neutron and Muon Source, https://doi.org/10.5286/ISIS.E.RB2410531-1
Data is released under the CC-BY-4.0 license.